Meeting
2023 ASCO Genitourinary Cancers Symposium
Length and Gleason pattern at positive surgical margin after radical prostatectomy to assess risk of postoperative recurrence in localized prostate cancer.
Authors
Masashi Kato
Nagoya University Graduate School of Medicine, Nagoya-Shi Showa-Ku, Japan
Masashi Kato , Toyonori Tsuzuki
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Therapeutics
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 359)
DOI
10.1200/JCO.2023.41.6_suppl.359
Abstract #
359
Poster Bd #
M17
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Risk of recurrence in patients with positive surgical margin at apex only versus other locations after radical prostatectomy.
First Author: Masashi Kato
Poster
2018 Genitourinary Cancers Symposium
Extended radical prostatectomy following neoadjuvant chemohormononal therapy (low dose estrmustine + LHRH agonist/antagonist) contributes to good cancer control for patients with high risk localized prostate cancer.
First Author: Hideki Enokida
Poster
2016 Genitourinary Cancers Symposium
![Detection of prostate cancer with the [<sup>68</sup>Ga]-labeled bombesin antagonist RM2 in patients undergoing radical prostatectomy.](https://d201v5jt9ylckg.cloudfront.net/172/10995/119611/119611_poster_pv.jpg)
Detection of prostate cancer with the [68Ga]-labeled bombesin antagonist RM2 in patients undergoing radical prostatectomy.
First Author: Andrew Stephens
Poster
2015 Genitourinary Cancers Symposium
Treatment outcomes of radiotherapy versus prostatectomy for localized prostate cancer with Gleason 8 or more on biopsy.
First Author: Christopher Baker Jr.